To the best of our knowledge, this is the first study to demonstrate the expression of SARS-CoV-2 receptor ACE2 and protease TMPRSS2 in patients with IPF through immunohistochemical methods. Here, ACE2 is linked to idiopathic pulmonary fibrosis.